Clinical Trials Directory

Trials / Unknown

UnknownNCT01400360

Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid Hemorrhage

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
92 (estimated)
Sponsor
Johann Wolfgang Goethe University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Cerebral vasospasm(CVS) after subarachnoid hemorrhage (SAH) results in a considerable amount of transient or even permanent neurological deficits and poor outcome of the patients. Transluminal Balloon angioplasty (TBA) or intraarterial application of vasodilators represents a rescue therapy for severe CVS. Indication, duration and efficacy of this treatment, however, is still under debate. Aim of the study is to investigate if such a rescue treatment can significantly reduce new delayed ischemic cerebral deficits after SAH. Hypothesis is that the occurance of delayed infarcts can be reduced by repetetive intraarterial therapy to more than 50 %.

Conditions

Interventions

TypeNameDescription
OTHERCombination of TBA and intraarterial application of vasodilatorsIn the invasive arm CVS should be treated by intraarterial therapy and efficacy controlled by CT or MRI after 48 hours and if necessary repeated.

Timeline

Start date
2009-08-01
Primary completion
2011-08-01
First posted
2011-07-22
Last updated
2011-07-22

Locations

5 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01400360. Inclusion in this directory is not an endorsement.